KR860005022A - 항종양활성 물질의 제조방법 - Google Patents

항종양활성 물질의 제조방법

Info

Publication number
KR860005022A
KR860005022A KR1019850009675A KR850009675A KR860005022A KR 860005022 A KR860005022 A KR 860005022A KR 1019850009675 A KR1019850009675 A KR 1019850009675A KR 850009675 A KR850009675 A KR 850009675A KR 860005022 A KR860005022 A KR 860005022A
Authority
KR
South Korea
Prior art keywords
active substance
tumor active
manufacturing anti
tumor
manufacturing
Prior art date
Application number
KR1019850009675A
Other languages
English (en)
Other versions
KR930012106B1 (ko
Inventor
사또루 나까이
마유미 가네다
요시까즈 기꾸모또
홍영만
가즈요시 가와이
세쓰꼬 다께가따
기요시 이시이
야스오 야나기하라
요시가쓰 히라이
Original Assignee
오오쓰까세이야꾸 가부시끼가이샤
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP60283238A external-priority patent/JPS62142121A/ja
Application filed by 오오쓰까세이야꾸 가부시끼가이샤 filed Critical 오오쓰까세이야꾸 가부시끼가이샤
Publication of KR860005022A publication Critical patent/KR860005022A/ko
Application granted granted Critical
Publication of KR930012106B1 publication Critical patent/KR930012106B1/ko

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C07K14/545—IL-1
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
KR1019850009675A 1984-12-21 1985-12-21 항종양활성 물질의 제조방법 KR930012106B1 (ko)

Applications Claiming Priority (10)

Application Number Priority Date Filing Date Title
JP27120784 1984-12-21
JP271207/84 1984-12-21
JP13828185 1985-06-24
JP13828085 1985-06-24
JP138280/85 1985-06-24
JP138281/85 1985-06-24
JP22088285 1985-10-03
JP220882/85 1985-10-03
JP283238/85 1985-12-16
JP60283238A JPS62142121A (ja) 1985-12-16 1985-12-16 抗腫瘍活性物質

Publications (2)

Publication Number Publication Date
KR860005022A true KR860005022A (ko) 1986-07-16
KR930012106B1 KR930012106B1 (ko) 1993-12-24

Family

ID=27527509

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019850009675A KR930012106B1 (ko) 1984-12-21 1985-12-21 항종양활성 물질의 제조방법

Country Status (5)

Country Link
US (1) US4898818A (ko)
EP (1) EP0187991B1 (ko)
KR (1) KR930012106B1 (ko)
DE (2) DE3586050D1 (ko)
DK (1) DK172052B1 (ko)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0569687B1 (en) * 1984-05-18 2002-08-21 New England Medical Center Hospitals, Inc. Human IL-1 cDNA sequences encoding biologically-active human IL-1 proteins
US5998578A (en) * 1984-05-18 1999-12-07 New England Medical Center Hospitals, Inc. Biologically active fragments of IL-1β
IE61353B1 (en) * 1984-06-19 1994-11-02 Immunex Corp Purified interleukin 1
JP2583770B2 (ja) 1986-09-17 1997-02-19 大塚製薬株式会社 遺伝子
DK590387A (da) * 1986-11-13 1988-05-14 Otsuka Pharma Co Ltd Antistoffer mod interleukin-1
US5047505A (en) * 1987-01-27 1991-09-10 Du Pont Merck Pharmaceutical Company High level expression in E. coli of soluble mature HIL-1beta and derivatives with altered biological activity
DK172424B1 (da) * 1988-07-29 1998-06-08 Otsuka Pharma Co Ltd IL-1alfa-Derivater, farmaceutisk præparat omfattende sådanne derivater, anvendelse af IL-1alfa-derivater, DNA sekvenser kod
FR2636231A1 (fr) * 1988-09-09 1990-03-16 Sanofi Sa Cellules eucaryotes recombinees productrices d'interleukine-1 (beta) mature n-glycosylee, procede et vecteurs necessaires pour leur obtention et procede d'obtention d'interleukine-1 (beta) mature n-glycosylee
EP0364778B1 (en) * 1988-10-01 1996-03-13 Otsuka Pharmaceutical Co., Ltd. Antibody against interleukin-1beta
US5649904A (en) * 1988-10-07 1997-07-22 Sandoz Ltd. Method of treating cancer with a fully myeloablative regimen of chemotherapy, radiation or both
DE3907244A1 (de) * 1989-03-07 1990-09-13 Knoll Ag Erzeugnisse, enthaltend ein lithiumsalz und einen tumor-nekrose-faktor
DE3922089A1 (de) * 1989-05-09 1990-12-13 Basf Ag Neue proteine und ihre herstellung
US6262239B1 (en) 1989-05-18 2001-07-17 Yeda Research And Development Co., Ltd. TNF receptor-specific antibodies
US6232446B1 (en) 1989-05-18 2001-05-15 Yeda Research And Development Co. Ltd. TNF ligands
US5849282A (en) * 1990-05-09 1998-12-15 Otsuka Pharmaceutical Co., Ltd. Method of treating colon, renal, and lung carcinomas with γ-interferon and Ser71 !-interleukin-1β
US5723117A (en) * 1990-08-10 1998-03-03 Otsuka Pharmaceutical Co., Ltd. Use of interleukin-1 (IL-1) to inhibit development of hepatitis
US6446032B1 (en) * 1990-09-21 2002-09-03 Massachusetts Institute Of Technology Designing compounds specifically inhibiting ribonucleic acid by binding to the minor groove
GB9112553D0 (en) * 1991-06-11 1991-07-31 Wellcome Found Fusion proteins
US7276335B1 (en) * 1993-09-29 2007-10-02 Massachusetts Institute Of Technology Designing compounds specifically inhibiting ribonucleic acid function
US6120770A (en) * 1997-09-12 2000-09-19 University Of Notre Dame Du Lac Plasmodium proteins useful for preparing vaccine compositions
GB9916630D0 (en) * 1999-07-16 1999-09-15 Univ Manchester Molecules derived from interleukins
GB0525866D0 (en) * 2005-12-20 2006-02-01 Cambridge Microbial Technologi Chemical induction of quiescence in cells
AU2011283669A1 (en) 2010-07-29 2013-02-07 Eleven Biotherapeutics, Inc. Chimeric IL-1 receptor type I agonists and antagonists
PL2968468T3 (pl) 2013-03-13 2021-12-20 Buzzard Pharmaceuticals AB Preparaty chimerycznej cytokiny do dostarczania do oka

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI82266C (fi) * 1982-10-19 1991-02-11 Cetus Corp Foerfarande foer framstaellning av il-2 -mutein.
FR2550802B1 (fr) * 1983-08-17 1986-04-11 Inst Nat Sante Rech Med Procede de production d'interleukine 1 humaine et medicaments correspondants
JPS60149386A (ja) * 1984-01-17 1985-08-06 Dainippon Pharmaceut Co Ltd インタ−ロイキン１をコ−ドする伝令リボ核酸及びその調製法
EP0155433A1 (en) * 1984-03-23 1985-09-25 Adriano Fontana Immunosuppressant factor
CA1341401C (en) * 1984-03-23 2002-11-26 Adriano Fontana Immunosuppressant factor derived from human glioblastoma cells
EP0569687B1 (en) * 1984-05-18 2002-08-21 New England Medical Center Hospitals, Inc. Human IL-1 cDNA sequences encoding biologically-active human IL-1 proteins
US4762914A (en) * 1984-05-18 1988-08-09 Auron Philip E Truncated protein of interleukin-1
DE3587669T2 (de) * 1984-05-18 1994-03-31 New England Medical Center Inc Menschliche IL-1-cDNS-Sequenzen die für biologisch aktive menschliche IL-1-Proteine kodieren.
IE61353B1 (en) * 1984-06-19 1994-11-02 Immunex Corp Purified interleukin 1
EP0188920B1 (en) * 1984-12-25 1993-09-29 Dainippon Pharmaceutical Co., Ltd. Interleukin 1 and its derivative
AU577856B2 (en) * 1985-01-17 1988-10-06 Immunex Corporation Cloning and characterization of the human interleukin 1 gene
EP0200986B2 (en) * 1985-04-25 1998-03-11 F. Hoffmann-La Roche Ag Recombinant human interleukin-1

Also Published As

Publication number Publication date
EP0187991A2 (en) 1986-07-23
DE3586050D1 (ko) 1992-06-17
US4898818A (en) 1990-02-06
KR930012106B1 (ko) 1993-12-24
EP0187991A3 (en) 1988-03-16
DE187991T1 (de) 1987-04-30
DK586685A (da) 1986-06-22
DK172052B1 (da) 1997-09-29
DK586685D0 (da) 1985-12-17
EP0187991B1 (en) 1992-05-13

Similar Documents

Publication Publication Date Title
KR860005022A (ko) 항종양활성 물질의 제조방법
KR870700614A (ko) -1-아릴-2-아실아미도-3-플루오로-1-프로판올의 제조방법
DE3579315D1 (de) Elektroden-herstellungsverfahren.
KR850006258A (ko) 반도체장치 제조방법
KR860002903A (ko) 프로그램가능한 반도체 구조
KR850700044A (ko) 이온 반응 에칭용 장치 제조방법
KR870700615A (ko) 감마-부티로락톤의 제조방법
IT1182843B (it) Metodo di registrazione
KR860004893A (ko) 신규 β-락탐의 제조방법
KR860000710A (ko) 반도체장치 제조방법
KR860005602A (ko) 즉석면류의 제조방법
FR2582197B1 (fr) Procede de fabrication de casques de
KR890701228A (ko) 9Ok초전도체 제조를 위한 개선된 방법
IT1191441B (it) Metodo per la fabbricazione di stampi
KR860004922A (ko) N-포르밀-α-아스파르틸페닐알라닌의 제조방법
KR860700123A (ko) 항생물질 l17392의 제조 방법
DE3686805T2 (de) Herstellungsverfahren von beta-lactamabkoemmlingen.
KR860700031A (ko) 살충제 화합물의 제조방법
KR870700632A (ko) 네틸마이신의 제조방법
KR860004453A (ko) 불순물 확산방법
KR870700597A (ko) 우레탄의 제조 방법
BR8505826A (pt) Inseticida de bromodicloro imidazol
KR860004941A (ko) 아실-락탐화합물을 제조하는 방법
PL263134A1 (en) Method for manufacturing optically active 2-chlor-12-(3-dimethylamine-2-methylpropyl)-12h-dibenzo dioxazotin
KR860004877A (ko) 카보스티릴 화합물의 제조방법

Legal Events

Date Code Title Description
A201 Request for examination
G160 Decision to publish patent application
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 19981126

Year of fee payment: 6

LAPS Lapse due to unpaid annual fee